[HTML][HTML] Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?
V Bajaj, N Gadi, AP Spihlman, SC Wu, CH Choi… - Frontiers in …, 2021 - frontiersin.org
The novel coronavirus severe acute respiratory syndrome coronavirus 2 causing the
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total …
Coronavirus disease (COVID-19) pandemic has ravaged the world with over 72 million total …
Treatment for COVID-19: An overview
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …
[HTML][HTML] Laboratory diagnosis of COVID-19
ES Goudouris - Jornal de pediatria, 2021 - SciELO Brasil
Objectives: This was a non-systematic review of the literature on the laboratory diagnosis of
COVID-19. Data sources: Searches in PubMed and Google Scholar for articles made …
COVID-19. Data sources: Searches in PubMed and Google Scholar for articles made …
[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–current perspectives
JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
Pregnant women with SARS‐CoV‐2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort …
RJ Martinez‐Portilla, A Sotiriadis… - … in Obstetrics & …, 2021 - Wiley Online Library
Objective There are limited, unmatched data reporting low complication rates in pregnant
women with coronavirus disease 2019 (COVID‐19). The aim of this study was to compare …
women with coronavirus disease 2019 (COVID‐19). The aim of this study was to compare …
[HTML][HTML] The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
The novel coronavirus SARS-CoV-2 enters into the human body mainly through the ACE2+
TMPRSS2+ nasal epithelial cells. The initial host response to this pathogen occurs in a …
TMPRSS2+ nasal epithelial cells. The initial host response to this pathogen occurs in a …
A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world
This paper is devoted to the multidisciplinary modelling of a pandemic initiated by an
aggressive virus, specifically the so-called SARS–CoV–2 Severe Acute Respiratory …
aggressive virus, specifically the so-called SARS–CoV–2 Severe Acute Respiratory …
Respiratory aerosols and droplets in the transmission of infectious diseases
ML Pöhlker, C Pöhlker, OO Krüger, JD Förster… - Reviews of Modern …, 2023 - APS
Knowing the physicochemical properties of exhaled droplets and aerosol particles is a
prerequisite for a detailed mechanistic understanding and effective prevention of the …
prerequisite for a detailed mechanistic understanding and effective prevention of the …
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
K Sriram, PA Insel - Physiological reviews, 2021 - journals.physiology.org
Evolving information has identified disease mechanisms and dysregulation of host biology
that might be targeted therapeutically in coronavirus disease 2019 (COVID-19). Thrombosis …
that might be targeted therapeutically in coronavirus disease 2019 (COVID-19). Thrombosis …
[HTML][HTML] Combination of ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome: a controlled study
To date, there are no specific therapeutic strategies for treatment of COVID-19. Based on the
hypothesis that complement and coagulation cascades are activated by viral infection, and …
hypothesis that complement and coagulation cascades are activated by viral infection, and …